Accumulation of cytosolic DNA due to reduced DNase II activity triggers aberrant TLR9 signaling, upregulating IFN‐β expression and inducing RIPK1‐dependent necroptotic hepatocyte death, thereby driving liver fibrosis and NAFLD.56 The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatotic liver disease.